| 0 (0%) | 01-27 03:19 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 38.38  |
1-year : | 41.34 |
| Resists | First : | 32.86 |
Second : | 35.4 |
| Pivot price | 31.59 |
|||
| Supports | First : | 28.76 |
Second : | 23.92 |
| MAs | MA(5) : | 30.14 |
MA(20) : | 31.61 |
| MA(100) : | 33.87 |
MA(250) : | 47.52 |
|
| MACD | MACD : | -0.9 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 10.7 |
D(3) : | 14.2 |
| RSI | RSI(14): 40.2  |
|||
| 52-week | High : | 75.29 | Low : | 27.79 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PRCT ] has closed above bottom band by 21.0%. Bollinger Bands are 16.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 29.97 - 30.14 | 30.14 - 30.29 |
| Low: | 28.32 - 28.54 | 28.54 - 28.74 |
| Close: | 29.29 - 29.61 | 29.61 - 29.9 |
Mon, 26 Jan 2026
Surgery robot firm PROCEPT plans Feb. 25 investor day at Nasdaq HQ - Stock Titan
Sun, 25 Jan 2026
Did AquaBeam Milestones and Options Activity Just Shift PROCEPT BioRobotics' (PRCT) Investment Narrative? - simplywall.st
Sat, 24 Jan 2026
(PRCT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Fri, 23 Jan 2026
A Look At PROCEPT BioRobotics (PRCT) Valuation As Regulatory And Clinical Catalysts Draw Investor Focus - simplywall.st
Wed, 21 Jan 2026
First Week of March 20th Options Trading For PROCEPT BioRobotics (PRCT) - Nasdaq
Fri, 16 Jan 2026
Promising growth forecasts leading to analysts’ optimism for Procept Biorobotics (PRCT) - MSN
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 56 (M) |
| Shares Float | 54 (M) |
| Held by Insiders | 4.4 (%) |
| Held by Institutions | 106.8 (%) |
| Shares Short | 6,720 (K) |
| Shares Short P.Month | 6,790 (K) |
| EPS | -1.53 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 6.8 |
| Profit Margin | -28.3 % |
| Operating Margin | -27.9 % |
| Return on Assets (ttm) | -13.1 % |
| Return on Equity (ttm) | -27.3 % |
| Qtrly Rev. Growth | 42.7 % |
| Gross Profit (p.s.) | 3.46 |
| Sales Per Share | 5.36 |
| EBITDA (p.s.) | -1.55 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -71 (M) |
| Levered Free Cash Flow | -49 (M) |
| PE Ratio | -19.36 |
| PEG Ratio | 0 |
| Price to Book value | 4.34 |
| Price to Sales | 5.51 |
| Price to Cash Flow | -23.29 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|